Thiery-Vuillemin, Antoine <br/><br/>
Anticancer therapy in patients with porphyrias: evidence today.  [electronic resource] 

 -  Expert opinion on drug safety  Mar 2008 
 - 159-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-764X 
<br/><br/><label>Standard No.: </label>10.1517/14740338.7.2.159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anastrozole<br/>Antineoplastic Agents--adverse effects<br/>Aromatase Inhibitors--adverse effects<br/>Breast Neoplasms--complications<br/>Docetaxel<br/>Epoetin Alfa<br/>Erythropoietin--adverse effects<br/>Female<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Hematinics--adverse effects<br/>Humans<br/>Letrozole<br/>Middle Aged<br/>Nitriles--adverse effects<br/>Porphyria, Acute Intermittent--complications<br/>Porphyria, Variegate--complications<br/>Recombinant Proteins<br/>Risk Assessment<br/>Taxoids--adverse effects<br/>Triazoles--adverse effects<br/>Uterine Neoplasms--complications